Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
K. Jeffrey Miller, DC, MBA
K. Jeffrey Miller, DC, MBA, is an assistant professor of chiropractic at the Missouri Orthopedic Institute, a branch of the University of Missouri Health System; and writes frequently on diagnosis and testing.